BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16728876)

  • 1. Baseline plasma N-terminal pro-B-type natriuretic peptide is associated with the extent of stress-induced myocardial ischemia during dobutamine stress echocardiography.
    Feringa HH; Elhendy A; Bax JJ; Boersma E; de Jonge R; Schouten O; Karagiannis SE; Schinkel AF; Lindemans J; Poldermans D
    Coron Artery Dis; 2006 May; 17(3):255-9. PubMed ID: 16728876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.
    Feringa HH; Schouten O; Dunkelgrun M; Bax JJ; Boersma E; Elhendy A; de Jonge R; Karagiannis SE; Vidakovic R; Poldermans D
    Heart; 2007 Feb; 93(2):226-31. PubMed ID: 16914484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline natriuretic peptide levels in relation to myocardial ischemia, troponin T release and heart rate variability in patients undergoing major vascular surgery.
    Feringa HH; Vidakovic R; Karagiannis SE; de Jonge R; Lindemans J; Goei D; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2007 Dec; 18(8):645-51. PubMed ID: 18004116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia.
    Staub D; Jonas N; Zellweger MJ; Nusbaumer C; Wild D; Pfisterer ME; Mueller-Brand J; Perruchoud AP; Mueller C
    Am J Med; 2005 Nov; 118(11):1287. PubMed ID: 16271916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of N-terminal pro B-type natriuretic peptide levels after symptom-limited exercise to baseline and ischemia levels.
    van der Zee PM; Verberne HJ; van Spijker RC; van Straalen JP; Fischer JC; Sturk A; van Eck-Smit BL; de Winter RJ
    Am J Cardiol; 2009 Mar; 103(5):604-10. PubMed ID: 19231320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.
    Singh HS; Bibbins-Domingo K; Ali S; Wu AH; Schiller NB; Whooley MA
    Clin Cardiol; 2009 Aug; 32(8):447-53. PubMed ID: 19685518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute changes in N-terminal pro-brain natriuretic peptide induced by dobutamine stress echocardiography.
    Karabinos I; Karvouni E; Chiotinis N; Papadopoulos A; Simeonidis P; Tsolas O; Katritsis D
    Eur J Echocardiogr; 2007 Aug; 8(4):265-74. PubMed ID: 16849043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal-proB natriuretic peptide in patients with stable coronary artery disease evaluated for ischemia with myocardial perfusion imaging.
    Majstorov V; Pop GD; Vavlukis M; Peovska I; Maksimovik J; Vaskova O; Kuzmanovska S; Zdraveska-Kochovska M
    Bratisl Lek Listy; 2008; 109(7):293-7. PubMed ID: 18792482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic Peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes.
    Hong SN; Yoon NS; Ahn Y; Lim SY; Kim YS; Yun KH; Kang DK; Lee SH; Lee YS; Kim KH; Son IS; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Circ J; 2005 Dec; 69(12):1472-6. PubMed ID: 16308494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function.
    Xu L; Qian W; Li W; Liu J; He H; Li G; Cao Y; Yu Y
    Peptides; 2014 Feb; 52():143-8. PubMed ID: 24412773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
    Hamano K; Abe M; Komi R; Kobayashi S
    Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease.
    Scharhag J; Herrmann M; Weissinger M; Herrmann W; Kindermann W
    Clin Res Cardiol; 2007 Apr; 96(4):218-26. PubMed ID: 17323015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Value of N-Terminal Pro B-Type Natriuretic Peptide in Evaluating Obstructive Sleep Apnea in Patients With Coronary Artery Disease.
    Liu Y; Huang Z; Huang K; Li G; Luo J; Xu Y; Chen P; Chen J; Wang L
    J Clin Sleep Med; 2019 Oct; 15(10):1403-1409. PubMed ID: 31596204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
    Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
    Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.
    Sir JJ; Chung WY; Hwang SJ; Kang HJ; Cho YS; Koo BK; Chae IH; Choi DJ; Kim HS; Sohn DW; Kim CH; Oh BH; Park YB; Choi YS
    Int J Cardiol; 2008 Jun; 126(3):322-32. PubMed ID: 17544525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.